Amylyx Pharmaceuticals Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Brent holds above $100 as tanker attacks dampen hopes for Hormuz traffic recovery
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
- This is Morgan Stanley's only preferred sportswear stock
- S&P 500 ends down as oil tops $100 per barrel
- Trump promises $5,000 payout to U.S. adults if Republicans win election
- White House copper tariff plan stalls amid affordability concerns, sources say
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Rogers adds Sportsnet+ content to Xfinity TV packages for free
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Amylyx Pharmaceuticals (AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
March 30, 2022 4:51 PM EDT(Updated - March 30, 2022 4:51 PM EDT)
Amylyx Pharmaceuticals (NASDAQ: AMLX) Receives 6 No Votes, 4 Yes Votes From FDA Panel on AMX0035 for Treatment of ALS
... MoreAmylyx Pharmaceuticals (AMLX) Confirms Shares Halted Ahead of FDA Advisory Committee Meeting to Discuss NDA for AMX0035 for the Treatment of ALS
March 30, 2022 7:07 AM EDTAmylyx Pharmaceuticals (NASDAQ: AMLX) today announced that Nasdaq has halted trading of the companys common stock.
The U.S. Food and Drug Administrations (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) is meeting today to review the New Drug Application... More
